I-MAB

$59.19
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.71 (+1.21%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell I-MAB and other stocks, options, and ETFs commission-free!

About IMAB

I-Mab operates as a clinical stage biopharmaceutical company. It engages in the development and commercialization of biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zhang Zang on June 30, 2016 and is headquartered in Pudong, China. The listed name for IMAB is I-MAB American Depositary Shares.

CEO
Hua Qiong Shen
Employees
185
Headquarters
Pudong, Shanghai
Founded
2016
Market Cap
3.89B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
287.65K
High Today
$61.93
Low Today
$56.61
Open Price
$58.59
Volume
309.93K
52 Week High
$65.55
52 Week Low
$11.05

IMAB Earnings

-$0.68
-$0.45
-$0.23
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 24, Pre-Market

You May Also Like

POTX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure